Scribe Therapeutics Achieves Milestone for In Vivo Program in Collaboration with Sanofi
Scribe announced its initial research collaboration with Sanofi for CRISPR-based cell therapies to address oncology ...
Hosted on MSN27m
Intellia slashes workforce by 27% to focus on late stage CRISPR candidates
Intellia expects to incur charges of $8m associated with the reorganisation, which will likely be incurred in Q1 2025.
Le Lézard25m
RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Producttm (PEPtm) in Diabetic Foot Ulcers
RION, a clinical-stage regenerative medicine company at the forefront of exosome-based therapeutics, announced today that it has completed patient enrollment in its Phase 2 clinical trial for Purified ...
Le Lézard25m
A Medical Misdiagnosis Leads to an Inspirational Life Without Limbs
Shortly after arriving in Ottawa with her two young children, following her husband's appointment as Cameroon's High Commissioner (Ambassador) to Canada, Mercy Azoh-Mbi complained of fatigue, fever, a ...